浙江省中药材产业提升发展现状与对策

Current Situation and Countermeasures of Traditional Chinese Medicines in Zhejiang

2015年浙江省中药材种植面积3.86万hm2,总产量17.86万t,总产值52.91亿元,形成了以"浙八味"—浙贝母(Fritillaria thunbergii)、杭白菊(Dendranthema morifolium)、延胡索(Corydalis yanhusuo)、白术(Atractylodes macrocephala)、玄参(Scrophularia ningpoensis)、浙麦冬(Ophiopogon japonicus)、杭白芍(Paeonia lactiflora)、温郁金(Curcuma aromatica cv.Wenyujin)为主的传统道地药材和铁皮石斛(Dendrobium officinale)、番红花(Crocus sativus)、灵芝(Ganoderma lucidum)等新兴特色药材优势产业。指出了制约中药材产业发展的问题,如中药材资源保护开发相对滞后、产品质量安全生产隐患多、抗市场风险能力较弱、产地初(精)加工受制约、品牌保护意识不强等。提出了贯彻产业发展规划和意见、加大资源保护与开发力度、加强规范化基地建设、推进标准化安全生产、做大做强铁皮石斛产业、着力培育"浙产药材"品牌、加强科技人才培养的发展对策。

In 2015, planting area, total yield and total output value of traditional Chinese medicines in Zhejiang province reached 38,600ha, 178,600t and 5.291 billion Yuan RMB. Eight dao-di herbs in the province like Fritillaria thunbergii, Dendranthema morifolium, Corydalis yanhusuo, Atractylodes macrocephala, Scrophularia ningpoensis, Ophiopogon japonicus, Paeonia lactiflora and Curcuma aromatica cv. Wenyujin and new developed medicines such as Dendrobium officinale, Crocus sativus and Ganoderma lucidum have been great advantages in the market. Advices were put forwarded for further development like protection of resources, standardization of base establishment and production, etc.